# CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer

> **NCT00154804** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Paclitaxel, Cisplatin,Surgery, CCRT

## Key facts

- **NCT ID:** NCT00154804
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2007-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154804, "CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00154804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*